Afficher la notice abrégée

dc.contributor.authorRuiz Montero, Rafael
dc.contributor.authorSerrano-Ortiz, Álvaro
dc.contributor.authorRivera Izquierdo, Mario 
dc.contributor.authorGalvache Murillo-Rico, Piedad
dc.contributor.authorMoñiz Díez, Ana
dc.contributor.authorOnieva García, María Ángeles
dc.contributor.authorGirela López, Eloy
dc.contributor.authorSalcedo-Leal, Inmaculada
dc.date.accessioned2025-03-24T09:16:34Z
dc.date.available2025-03-24T09:16:34Z
dc.date.issued2025-03-08
dc.identifier.citationRuiz-Montero, R.; Serrano-Ortiz, Á.; Rivera-Izquierdo, M.; Galvache Murillo-Rico, P.; Moñiz-Díez, A.; Onieva-García, M.Á.; Girela-López, E.; Salcedo-Leal, I. Meningococcal Vaccination in High-Risk Patients: A Systematic Approach to Evaluating Coverage and Patient Catch-Up Through Healthcare Databases. Vaccines 2025, 13, 287. https://doi.org/10.3390/vaccines13030287es_ES
dc.identifier.urihttps://hdl.handle.net/10481/103263
dc.descriptionThe publication costs were funded by the research group CTS-295 in Preventive Medicine and Public Health, University of Córdoba.es_ES
dc.description.abstractBackground: Invasive meningococcal disease (IMD) can lead to severe and fatal outcomes. Vaccines against meningococcus (serogroups B, MenB; or ACWY, MenACWY) are recommended for patients at high risk of developing IMD. Our aim was to identify high-risk patients through a systematic search of medical codes and to evaluate vaccination coverage by high-risk group. Methods: An observational retrospective study was conducted in patients discharged at Reina Sofía University Hospital (Cordoba, Spain) from 1 January 2000, to 31 December 2023. Selection of high-risk patients was conducted through national administrative and clinical databases and vaccination coverage was determined through the Andalusian electronic vaccine database. Vaccine coverages of MenB and MenACWY were calculated within risk groups. Finally, bivariate analyses were conducted to assess the potential association between coverage, sex, and the year of admission. Results: A total of 2689 patients with 2710 high-risk conditions for IMD were identified from the databases searched. Of the 1755 requiring MenB vaccination, only 624 (35.6%) had received one dose and 558 (31.8%) two doses. Of the 2710 requiring MenACWY vaccination, only 784 (28.9%) had received one dose and 520 (19.2%) two doses. Patients with properdin-complement deficiencies showed the lowest vaccination rates (<10%). For the rest of the high-risk groups, vaccination coverages were significantly lower when the condition was diagnosed before the immunization guideline recommendations (p < 0.001). Conclusions: The identification of high-risk patients through databases using R-coded algorithms is both feasible and effective for identifying and catching-up patients for vaccination. The population at risk of IMD lacks adequate meningococcal vaccination coverage. Our methodology can serve to identify patients in other regions and for different vaccines.es_ES
dc.description.sponsorshipUniversity of Córdoba CTS-295es_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectMeningococcal infectionses_ES
dc.subjectNeisseria meningitidis es_ES
dc.subjectVaccination es_ES
dc.subjectVaccination coveragees_ES
dc.subjectImmunization programses_ES
dc.titleMeningococcal Vaccination in High-Risk Patients: A Systematic Approach to Evaluating Coverage and Patient Catch-Up Through Healthcare Databaseses_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.3390/vaccines13030287
dc.type.hasVersionVoRes_ES


Fichier(s) constituant ce document

[PDF]

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

Atribución 4.0 Internacional
Excepté là où spécifié autrement, la license de ce document est décrite en tant que Atribución 4.0 Internacional